Trial Profile
Value of gadofosveset-enhanced MRI and multiplanar reformatting for selecting good responders after chemoradiation for rectal cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Gadofosveset (Primary)
- Indications Rectal cancer
- Focus Diagnostic use
- 21 Dec 2015 New trial record